Cybin Inc. (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative ...

(SILO), Monday announced positive results from a pre-clinical study of SPC-15 showing potential for the treatment of major depressive disorder, and other severe stress-related conditions ... severe ...

Cybin has reported 71% remission in patients with major depressive disorder (MDD) who received two doses of the ... that are ...

This new formulation, which targets both the serotonin 5-HT4 receptor (5-HT4R) and the NMDA receptor (NMDAR), has shown ...

This new formulation, which targets both the serotonin 5-HT4 receptor (5-HT4R) and the NMDA receptor (NMDAR), has shown potential as a treatment for major depressive disorder (MDD), and other severe ...

and major depressive disorder (MDD)," said Rob Barrow, Chief Executive Officer of MindMed. "Gregg’s deep expertise in leading ...

One major approach is to learn what ... The role of exposure in treatment of anxiety disorders: A meta-analysis.

Mental health, a topic that sends chills down the spine, is no longer a phenomenon that ‘happens to others’. According to the ...

My teen has tried three different online therapy services, but Fort Health was the best experience by far. Read my full ...

In 2023, the number of cases related to Parkinson's disease was 2.16 million and this is expected to grow up to 3.15 million ...

Can turmeric really clear up acne and fade scars? Discover what science says about this ancient remedy and how to safely use ...

As the leaves conclude their falling and the temperature begins to drop, spirits tend to decline as well. Whether it’s caused ...